Literature DB >> 2095572

Mechanism of L-alpha-methyldopa transport through a monolayer of polarized human intestinal epithelial cells (Caco-2).

M Hu1, R T Borchardt.   

Abstract

The Caco-2 model system (Hidalgo et al., Gastroenterology, 96:736-749, 1989), which is a monolayer of polarized intestinal epithelial cells grown onto a porous polycarbonate membrane, was used to study the mechanism of transcellular transport of an antihypertensive agent, L-alpha-methyldopa (L-alpha-MD). The results showed that the transport of L-alpha-MD was pH, glucose, concentration, and temperature dependent, and it could be inhibited by metabolic inhibitors (e.g., 2,4-dinitrophenol) and by amino acids (e.g., L-phenylalanine) which have an affinity for the large neutral amino acid (LNAA) carrier. In addition, the apparent kinetic constants describing the transcellular transport of L-alpha-MD were altered depending on the time interval between feeding the cells and the transport experiments (postfeeding time, PFT). The apparent maximum carrier flux (Jmax) of L-alpha-MD was significantly increased (from 155 to 547 pmol/mg protein/min) when PFT was prolonged from 8.5 to 56 hr. These results indicated that the transcellular transport of L-alpha-MD through the polarized Caco-2 cell monolayer was carrier mediated via the LNAA carrier. The similarities in the characteristics of L-alpha-MD transport exhibited by the Caco-2 model system and other intestinal models in vitro further substantiate the usefulness of this cell culture model for studying the intestinal transport of nutrients and drugs.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2095572     DOI: 10.1023/a:1015906409585

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  21 in total

1.  STUDIES ON THE METABOLISM AND MECHANISM OF ACTION OF METHYLDOPA.

Authors:  A SJOERDSMA; A VENDSALU; K ENGELMAN
Journal:  Circulation       Date:  1963-10       Impact factor: 29.690

2.  Use of the peptide carrier system to improve the intestinal absorption of L-alpha-methyldopa: carrier kinetics, intestinal permeabilities, and in vitro hydrolysis of dipeptidyl derivatives of L-alpha-methyldopa.

Authors:  M Hu; P Subramanian; H I Mosberg; G L Amidon
Journal:  Pharm Res       Date:  1989-01       Impact factor: 4.200

3.  The mechanism of the antihypertensive action of -methyldopa in hypertensive rats.

Authors:  M D Day; A G Roach; R L Whiting
Journal:  Eur J Pharmacol       Date:  1973-03       Impact factor: 4.432

4.  The effect of pH and concentration on alpha-methyldopa absorption in man.

Authors:  A E Merfeld; A R Mlodozeniec; M A Cortese; J B Rhodes; J B Dressman; G L Admidon
Journal:  J Pharm Pharmacol       Date:  1986-11       Impact factor: 3.765

5.  Pharmacokinetics of methyldopa in man.

Authors:  K C Kwan; E L Foltz; G O Breault; J E Baer; J A Totaro
Journal:  J Pharmacol Exp Ther       Date:  1976-08       Impact factor: 4.030

Review 6.  Exploiting amino acid structure to learn about membrane transport.

Authors:  H N Christensen
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1979

7.  The absorption and excretion of methyldopa ingested concomitantly with amino acids or food rich in protein.

Authors:  O Stenbaek; E Myhre; H E Rugstad; E Arnold; T Hansen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1982-03

8.  Sulfate and methyldopa metabolism: metabolite patterns and platelet phenol sulfotransferase activity.

Authors:  N R Campbell; R S Sundaram; P G Werness; J Van Loon; R M Weinshilboum
Journal:  Clin Pharmacol Ther       Date:  1985-03       Impact factor: 6.875

9.  The metabolism of 14 C-labelled -methyldopa in normal and hypertensive human subjects.

Authors:  W Y Au; L G Dring; D G Grahame-Smith; P Isaac; R T Williams
Journal:  Biochem J       Date:  1972-08       Impact factor: 3.857

10.  Common characteristics for Na+-dependent sugar transport in Caco-2 cells and human fetal colon.

Authors:  A Blais; P Bissonnette; A Berteloot
Journal:  J Membr Biol       Date:  1987       Impact factor: 1.843

View more
  15 in total

Review 1.  Targeted prodrug design to optimize drug delivery.

Authors:  H K Han; G L Amidon
Journal:  AAPS PharmSci       Date:  2000

2.  Effect of food on the bioavailability of SDZ DJN 608, an oral hypoglycemic agent, from a tablet and a liquid-filled capsule in the dog.

Authors:  F L Tse; D Labbadia; K Habucky; A Karara; S Au
Journal:  Pharm Res       Date:  1996-03       Impact factor: 4.200

Review 3.  Modeling kinetics of subcellular disposition of chemicals.

Authors:  Stefan Balaz
Journal:  Chem Rev       Date:  2009-05       Impact factor: 60.622

Review 4.  Carrier-mediated intestinal transport of drugs.

Authors:  A Tsuji; I Tamai
Journal:  Pharm Res       Date:  1996-07       Impact factor: 4.200

5.  Transport of the antibacterial agent oxazolidin-2-one and derivatives across intestinal (Caco-2) and renal (MDCK) epithelial cell lines.

Authors:  G Ranaldi; P Seneci; W Guba; K Islam; Y Sambuy
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

6.  Breast cancer resistance protein (ABCG2) determines distribution of genistein phase II metabolites: reevaluation of the roles of ABCG2 in the disposition of genistein.

Authors:  Zhen Yang; Wei Zhu; Song Gao; Taijun Yin; Wen Jiang; Ming Hu
Journal:  Drug Metab Dispos       Date:  2012-06-26       Impact factor: 3.922

7.  In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man--fact or myth.

Authors:  S Yee
Journal:  Pharm Res       Date:  1997-06       Impact factor: 4.200

8.  Transepithelial transport and metabolism of thyrotropin-releasing hormone (TRH) in monolayers of a human intestinal cell line (Caco-2): evidence for an active transport component?

Authors:  E Walter; T Kissel
Journal:  Pharm Res       Date:  1994-11       Impact factor: 4.200

9.  Utilization of a human intestinal epithelial cell culture system (Caco-2) for evaluating cytoprotective agents.

Authors:  A S Tang; P J Chikhale; P K Shah; R T Borchardt
Journal:  Pharm Res       Date:  1993-11       Impact factor: 4.200

10.  Comparison of the transport characteristics of D- and L-methionine in a human intestinal epithelial model (Caco-2) and in a perfused rat intestinal model.

Authors:  L Zheng; J Chen; Y Zhu; H Yang; W Elmquist; M Hu
Journal:  Pharm Res       Date:  1994-12       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.